Gastrointestinal Diseases Clinical Trial
Official title:
A Randomized, Controlled Trial of Improved Gut Health Outcomes Associated With Probiotics Fortified With Hydrolyzed Whey Protein in Infant Formula
The goal of this interventional clinical trial is to test the effectiveness of improving gut health in terms of frequency of bowel movements in newly born infants fed with Feihe investigational formula product containing probiotics fortified with hydrolyzed hey protein. The main question it aims to answer is: - whether the frequency of bowel movements (through 12 months) of participants in the study product arm is significantly better than participants assigned in the other two arms. 240 qualified participants will be randomized to 3 arms (investigational formula, control formula, and breast-feeding) to consume assigned formula or breast-feeding for 12 months according to protocol. There will be up to 6 site visits arranged for each participant during the study, and all relevant clinical and questionnaire data, including the most important primary outcome - frequency of bowel movements through 12 months, will be captured, recorded and entered to CMTS (Clinical Management Trial System) for statistical analysis and reporting. Researchers will compare the three arms to validate the assumption that the consumption of Feihe investigational formula product containing probiotics fortified with hydrolyzed hey protein will improve gut health in newly born infants, along with physical development.
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT02541357 -
Preoperative Relaxation and Intensified Patient Surgery Education in Patients Undergoing Colorectal Surgery
|
N/A | |
| Active, not recruiting |
NCT02358122 -
Determining the Potential of Wholegrain Wheat and Rye to Improve Gut HealTh
|
N/A | |
| Active, not recruiting |
NCT02442115 -
Impact of Improving GI Symptoms on Autism Symptoms and Oxidative Stress
|
||
| Enrolling by invitation |
NCT00943345 -
Validation of New Tests for Gastrointestinal (GI) Permeability
|
Phase 0 | |
| Completed |
NCT00612404 -
Symptoms and Endoscopic Results in Consideration of Pretreatment
|
N/A | |
| Completed |
NCT01127711 -
Cohort of Swedish Men
|
N/A | |
| Recruiting |
NCT05712525 -
Gut Recovery In Patients Following Surgery
|
||
| Recruiting |
NCT06094153 -
Prebiotic Effects on Gut Microbiota, Gut Comfort and Immune Function
|
N/A | |
| Recruiting |
NCT05322486 -
Palliative Primary Tumor Resection in Minimally Symptomatic Patients With Colorectal Cancer and Synchronous Unresectable Metastases
|
||
| Completed |
NCT02486146 -
GI Biorepository of Tissue and Bodily Fluids
|
N/A | |
| Completed |
NCT01816607 -
Functional MRI of Hypoxia-mediated Rectal Cancer Aggressiveness
|
||
| Completed |
NCT00247715 -
Comparison of a "Step-Up" Versus a "Step-Down" Treatment Strategy for Patients With New Onset Dyspepsia in General Practice (The DIAMOND-Study)
|
N/A | |
| Completed |
NCT00035334 -
Study of the Safety and Efficacy of NC-503 in Secondary (AA) Amyloidosis
|
Phase 2/Phase 3 | |
| Recruiting |
NCT06286865 -
Improving Quality of ICD-10 Coding Using AI: Protocol for a Crossover Randomized Controlled Trial
|
N/A | |
| Active, not recruiting |
NCT01037049 -
Optimum Timing for Surgery After Pre-operative Radiotherapy 6 vs 12 Weeks
|
Phase 2 | |
| Completed |
NCT03725813 -
Study Evaluating the Effect of Person-centred Care for Patients Admitted for Inpatient Care at an Internal Medicine Unit
|
N/A | |
| Recruiting |
NCT05640401 -
Holographic Screens as a Replacement of Monitors During GI Endoscopies
|
N/A | |
| Completed |
NCT02865564 -
Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics
|
N/A | |
| Completed |
NCT02651857 -
Exploratory Study of Upper and Lower Endoscopic Fuse System
|
N/A | |
| Active, not recruiting |
NCT01984034 -
Trial to Assess the Effectiveness of Educational Outreach in Prescription Guidelines
|
N/A |